Ebert M P, Leodolter A, Malfertheiner P
Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Leipzigerstr. 44 D-39120 Magdeburg, Germany.
Hepatogastroenterology. 2001 Nov-Dec;48(42):1569-71.
Helicobacter pylori has been classified as a human carcinogen contributing to the pathogenesis of gastric cancer. Eradication of H. pylori as a means towards preventing gastric cancers has become an interesting option, however, the scientific data supporting this practice are not well established. Therefore, large, multicenter trials have been initiated in order to assess and establish the scientific basis for this option. Reverting histomorphological and biochemical changes of the gastric mucosa after H. pylori eradication point to a beneficial effect of H. pylori eradication on the prevention of gastric cancers. This article will give a brief overview on the current knowledge on the pathogenesis of gastric cancer and the role of H. pylori in this regard and will also describe current approaches towards preventing gastric cancer.
幽门螺杆菌已被列为导致胃癌发病的人类致癌物。根除幽门螺杆菌作为预防胃癌的一种手段已成为一个有意思的选择,然而,支持这种做法的科学数据并不充分。因此,已启动大型多中心试验,以评估并确立这一选择的科学依据。根除幽门螺杆菌后胃黏膜组织形态学和生化变化的逆转表明,根除幽门螺杆菌对预防胃癌有有益作用。本文将简要概述目前关于胃癌发病机制的知识以及幽门螺杆菌在这方面的作用,还将描述目前预防胃癌的方法。